
CRISPR-Edited Viruses Offer New Path Against Antibiotic-Resistant Superbugs
Researchers are using CRISPR gene editing to create viruses that target and destroy antibiotic-resistant bacteria. Locus Biosciences has developed a blend of three engineered viruses that act as a 'living antibiotic,' potentially offering a new way to fight infections that evade current drugs.







